SEC Form 4 · accession 0001213900-18-013010
NEXEON MEDSYSTEMS INC · NXNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
William Rosellini
Officer — CHIEF EXECUTIVE OFFICER · Director · 10% Owner
Rosellini Scientific Holdings, LLC
10% Owner
Period of report
Sep 24, 2018
Accepted (ET)
Sep 25, 2018 · 8:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 24, 2018 | G | 367,785 | — | D | 741,027 | I | Held by Rosellini Scientific Holdings, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 24, 2018, Rosellini Scientific Holdings, LLC gifted 367,785 shares of Common Stock to Rosellini Family Irrevocable Trust, over which the Reporting Person does not hold voting or dispositive power.
- F2Give effect to the reverse stock split of the Issuer to its common stock at a ratio of 1-for-14, effective June 28, 2018.